Leonie Smeenk

1.4k total citations
19 papers, 838 citations indexed

About

Leonie Smeenk is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Leonie Smeenk has authored 19 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Hematology and 5 papers in Oncology. Recurrent topics in Leonie Smeenk's work include Acute Myeloid Leukemia Research (8 papers), Protein Degradation and Inhibitors (6 papers) and RNA modifications and cancer (5 papers). Leonie Smeenk is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Protein Degradation and Inhibitors (6 papers) and RNA modifications and cancer (5 papers). Leonie Smeenk collaborates with scholars based in Netherlands, Germany and Austria. Leonie Smeenk's co-authors include Simon J. van Heeringen, Marion Lohrum, Max Koeppel, Hendrik G. Stunnenberg, Eva M. Janssen‐Megens, Robert C. Akkers, Sergei Denissov, Marc A. van Driel, Stefanie J. J. Bartels and Meinrad Busslinger and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and The EMBO Journal.

In The Last Decade

Leonie Smeenk

18 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leonie Smeenk Netherlands 14 567 271 162 129 124 19 838
Pamela Mukhopadhyay Australia 19 641 1.1× 196 0.7× 198 1.2× 130 1.0× 123 1.0× 32 970
Andrea Newbold Australia 17 935 1.6× 295 1.1× 172 1.1× 139 1.1× 95 0.8× 28 1.2k
Clinton E. Leysath United States 16 621 1.1× 144 0.5× 227 1.4× 200 1.6× 55 0.4× 20 1.0k
Marie-Ève Bordeleau Canada 11 822 1.4× 92 0.3× 107 0.7× 180 1.4× 43 0.3× 13 1.1k
Max Koeppel Germany 10 500 0.9× 298 1.1× 172 1.1× 27 0.2× 197 1.6× 20 768
Kazuto Tsuruda Japan 19 456 0.8× 199 0.7× 665 4.1× 72 0.6× 122 1.0× 46 1.1k
Mary Jane McWilliams United States 15 557 1.0× 151 0.6× 103 0.6× 49 0.4× 67 0.5× 20 848
Bruce Fowler United States 12 428 0.8× 90 0.3× 172 1.1× 228 1.8× 222 1.8× 12 902
Xianbo Huang China 15 328 0.6× 140 0.5× 101 0.6× 79 0.6× 106 0.9× 42 606
Natalie Erdmann Canada 13 768 1.4× 220 0.8× 71 0.4× 167 1.3× 60 0.5× 18 1.1k

Countries citing papers authored by Leonie Smeenk

Since Specialization
Citations

This map shows the geographic impact of Leonie Smeenk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonie Smeenk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonie Smeenk more than expected).

Fields of papers citing papers by Leonie Smeenk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonie Smeenk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonie Smeenk. The network helps show where Leonie Smeenk may publish in the future.

Co-authorship network of co-authors of Leonie Smeenk

This figure shows the co-authorship network connecting the top 25 collaborators of Leonie Smeenk. A scholar is included among the top collaborators of Leonie Smeenk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonie Smeenk. Leonie Smeenk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Havermans, Marije, Roger Mulet‐Lazaro, Leonie Smeenk, et al.. (2025). MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia. Blood. 146(25). 3098–3105.
2.
Havermans, Marije, Roger Mulet‐Lazaro, Julius Gräsel, et al.. (2024). Oncogene EVI1 drives acute myeloid leukemia via a targetable interaction with CTBP2. Science Advances. 10(20). eadk9076–eadk9076. 6 indexed citations
3.
Schmoellerl, Johannes, Inês Amorim Monteiro Barbosa, Martina Minnich, et al.. (2022). EVI1 drives leukemogenesis through aberrant ERG activation. Blood. 141(5). 453–466. 19 indexed citations
4.
Schmoellerl, Johannes, Inês Amorim Monteiro Barbosa, Martina Minnich, et al.. (2022). S117: EVI1 DRIVES LEUKEMOGENESIS THROUGH ABERRANT ERG ACTIVATION. HemaSphere. 6. 18–19. 1 indexed citations
5.
Mulet‐Lazaro, Roger, Claudia Erpelinck-Verschueren, Marije Havermans, et al.. (2021). The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops. Nature Communications. 12(1). 5679–5679. 40 indexed citations
6.
Smeenk, Leonie, Roger Mulet‐Lazaro, Anja Ebert, et al.. (2021). Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia. Cancer Discovery. 11(11). 2868–2883. 29 indexed citations
7.
Avellino, Roberto, Roger Mulet‐Lazaro, Marije Havermans, et al.. (2021). Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null mice. Blood Advances. 6(5). 1406–1419. 7 indexed citations
8.
Mulet‐Lazaro, Roger, H. Berna Beverloo, Claudia Erpelinck-Verschueren, et al.. (2020). Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia. Blood. 136(2). 224–234. 44 indexed citations
9.
Mulet‐Lazaro, Roger, Berna Beverloo, Marije Havermans, et al.. (2018). Complex 3q26/EVI1 Rearrangements Genocopy Inv(3)/t(3;3) Acute Myeloid Leukemias By Enhancer Hijacking, EVI1 Overexpression, Absent MDS1-EVI1 and Low GATA2 Expression. Blood. 132(Supplement 1). 2766–2766. 1 indexed citations
10.
Smeenk, Leonie, Maria Fischer, Sabine Jurado, et al.. (2017). Molecular role of the PAX 5‐ ETV 6 oncoprotein in promoting B‐cell acute lymphoblastic leukemia. The EMBO Journal. 36(6). 718–735. 31 indexed citations
11.
Ahmad, Khalil Ali, Jessica Roos, Tomohiro Chiba, et al.. (2015). 5-Lipoxygenase is a direct p53 target gene in humans. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1849(8). 1003–1016. 29 indexed citations
12.
Revilla‐i‐Domingo, Roger, Ivan Bilić, Bojan Vilagos, et al.. (2012). The B‐cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis. The EMBO Journal. 31(14). 3130–3146. 161 indexed citations
13.
Smeenk, Leonie, Simon J. van Heeringen, Max Koeppel, et al.. (2011). Role of p53 Serine 46 in p53 Target Gene Regulation. PLoS ONE. 6(3). e17574–e17574. 144 indexed citations
14.
Koeppel, Max, Simon J. van Heeringen, Daniela Kramer, et al.. (2011). Crosstalk between c-Jun and TAp73α/β contributes to the apoptosis–survival balance. Nucleic Acids Research. 39(14). 6069–6085. 43 indexed citations
15.
Smeenk, Leonie, Simon J. van Heeringen, Max Koeppel, et al.. (2008). Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Research. 36(11). 3639–3654. 168 indexed citations
16.
Koeppel, Max, Simon J. van Heeringen, Leonie Smeenk, et al.. (2008). The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response. Nucleic Acids Research. 37(2). 322–335. 44 indexed citations
17.
Smeenk, Leonie, Itaru Anraku, Gorben P. Pijlman, et al.. (2008). A Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapy. Gene Therapy. 16(2). 190–199. 29 indexed citations
18.
Snippe, Marjolein, Leonie Smeenk, Rob Goldbach, & Richard Kormelink. (2007). The cytoplasmic domain of tomato spotted wilt virus Gn glycoprotein is required for Golgi localisation and interaction with Gc. Virology. 363(2). 272–279. 17 indexed citations
19.
Maanen, C. van, et al.. (2000). An equine herpesvirus 1 (EHV1) abortion storm at a riding school. Veterinary Quarterly. 22(2). 83–87. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pamela Mukhopadhyay Breakdown of academic impact, for papers by Andrea Newbold Breakdown of academic impact, for papers by Clinton E. Leysath Breakdown of academic impact, for papers by Marie-Ève Bordeleau Breakdown of academic impact, for papers by Max Koeppel Breakdown of academic impact, for papers by Kazuto Tsuruda Breakdown of academic impact, for papers by Mary Jane McWilliams Breakdown of academic impact, for papers by Bruce Fowler Breakdown of academic impact, for papers by Xianbo Huang Breakdown of academic impact, for papers by Natalie Erdmann
Rankless by CCL
2026